What we are studying
The drug we are testing in this study is called CTX-4430. Since it is still being studied, it is not yet approved or available for doctors to prescribe. It has been tested in people with and without cystic fibrosis. People with cystic fibrosis have taken CTX-4430 for 15 days. In these studies, CTX 4430 was well tolerated. We think CTX-4430 works by treating the inflamed tissue in the lungs of people with cystic fibrosis. Now we want to get more information on how well it works in treating people with cystic fibrosis and how safe and tolerable it is when taken once a day by mouth for 48 weeks.
You will be paid $1150.00 if you complete all the scheduled study visits. If you withdraw for any reason from the study before completion you will be paid the following for each complete study visit.
Visit 1 screening $100.00
Visit 2 baseline $100.00